Papaya Leaf Extract

Clinically shown to raise platelet counts — directly relevant during chemotherapy.

What it is

Papaya leaf extract (Carica papaya) has been used in Southeast Asia and the Caribbean traditionally for dengue fever, where platelet-raising effects were first documented. Modern research has identified active compounds — including acetogenins and carpaine — that appear to stimulate thrombopoiesis (platelet production from bone marrow megakaryocytes).

Why it matters

Thrombocytopenia (low platelet count) is one of the most common dose-limiting side effects of chemotherapy, frequently causing treatment delays or dose reductions. Papaya leaf extract has shown meaningful platelet-raising effects in clinical trials, making it directly relevant for maintaining treatment continuity.

The evidence

Multiple randomised controlled trials in dengue fever patients show 20–40% platelet improvements over 5–7 days. Small clinical studies specifically in chemotherapy patients (particularly in South and Southeast Asian oncology settings) show similar effects. Growing use in oncology adjunct protocols in Asian hospitals.

This information is for educational purposes and does not constitute medical advice. Always discuss supplement use with your care team, particularly if you are undergoing active cancer treatment.

Dosing

25–50ml cold-pressed papaya leaf juice, or 500–1000mg standardised leaf extract twice daily. Best taken consistently throughout treatment cycles, not just when platelets are low. Monitor platelet counts alongside use.

Cautions

Monitor platelet counts regularly when using. Avoid combining with anticoagulants (blood thinners) without medical supervision. Very high doses can cause GI irritation or hepatotoxicity — stay within recommended range. Discuss with oncologist as part of treatment support planning.